P Gp Or Bcrp Substrates + Mavorixafor Interaction
Moderateinteraction on record
Description
Increase mavorixafor Cmax and AUC. Monitor for adverse reactions and reduce dosage by 100 mg steps if necessary, but not below 200 mg.
Mechanism
Inhibition of P-glycoprotein-mediated efflux of mavorixafor
Source: NLP:mavorixafor